2025-12-06 - Analysis Report
Okay, here's a comprehensive analysis of Rocket Lab (RKLB) based on the data you provided, structured as requested.

**0) Report Summary**

**RKLB Overview:** Rocket Lab USA Inc is a space company providing launch services and space systems.

*   **Performance:** RKLB has significantly outperformed the S&P 500 recently, but has high volatility.
*   **Valuation:** Analyst consensus is bullish, but price targets are still above the current trading price.
*   **Financials:** Revenue is growing, but profitability remains a challenge.
*   **Outlook:** Recent news and analyst reports suggest a positive outlook driven by government contracts and successful launches, but delays of the Neutron project can be a concern.

**1) Return Rate Analysis**

*   **Cumulative Return (RKLB):** 235.19%
*   **Cumulative Return (VOO):** 50.70%
*   **Divergence:** 168.2 (Relative Divergence: 49.6)
*   **Analysis:**  RKLB has significantly outperformed the S&P 500. The divergence indicates a substantial difference in returns. However, the relative divergence being at 49.6 suggests that this level of outperformance, while significant, isn't exceptionally rare within RKLB's historical volatility.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha  | Beta  | Cap(B) |
|------------|--------|--------|--------|-------|--------|
| 2020-2022  | -38.0% | 82.7%  | -18.0% | 0.1   | 2.2    |
| 2021-2023  | 3.0%   | 82.7%  | 2.0%   | 0.0   | 3.2    |
| 2022-2024  | 210.0% | 82.7%  | 189.0% | 0.0   | 14.9   |
| 2023-2025  | 255.0% | 79.6%  | 189.0% | -0.0 | 26.2   |

*   **CAGR:**  Growth is improving over time, with significant increases in recent periods.
*   **MDD:** High Maximum Drawdown indicates substantial risk and volatility.  Be prepared for large potential price swings.
*   **Alpha:**  Shows consistent positive alpha (outperformance compared to a benchmark) in recent periods, suggesting RKLB's returns are not solely due to market movements.
*   **Beta:**  Beta is near zero or negative, indicating low correlation with the broader market. This could be a benefit during market downturns.
*   **Cap(B):**  Market capitalization is growing, suggesting increasing investor confidence.

**2) Recent Stock Price Fluctuations**

*   **Close:** 44.72
*   **Last-market:** price: 49.1512, previousClose: 49.37, change: -0.44 (Slight decline in the last market session)
*   **5-day SMA:** 42.542
*   **20-day SMA:** 45.441
*   **60-day SMA:** 53.4778

**Analysis:** The 5-day SMA is below the 20-day SMA, and both are below the 60-day SMA.  This suggests a recent upward trend that may be losing momentum. The recent price is below the 20-day SMA, indicating a possible pullback.

**3) RSI, PPO, and Hybrid Signal Analysis**

*   **MRI:** 0.8 (Medium Investment Recommendation)
*   **RSI:** 36.92 (Approaching Oversold)
*   **PPO:** 0.3238 (Positive, but not excessively high)
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (40 shares - Safe - MRI:0.80) (Cash Ratio: 0% on 2025-12-03)
*   **Recent Relative Divergence Change:** 2.5 (+) (Short-term increase)
*   **Expected Return (%):** 16.2

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI indicates the stock might be approaching oversold conditions, which could signal a potential buying opportunity.
*   The positive PPO suggests that the short-term moving average is above the long-term moving average, which is typically considered a bullish sign.
*   The Hybrid Signal suggests a strong buy recommendation.
*   The short-term increase in relative divergence supports the potential buying opportunity.
*   The expected return of 16.2% is a significant potential upside if held long-term.

**4) Recent News & Significant Events**

*   **Key Themes:** The news headlines indicate positive momentum for Rocket Lab, driven by record launches, a deal with JAXA (Japan Aerospace Exploration Agency), and potential upside due to government work. The "Rocket Lab Paradox" headline suggests a more nuanced view that may warrant further investigation. The delay of the Neutron project is also highlighted.
*   **Impact:** The news is generally bullish, suggesting a positive outlook for the company. Positive outlook and rating upgrades.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.79)
*   **Target Price (avg/high/low):** 65.67 / 83.00 / 47.00

**Analysis:**  Analysts are generally positive on RKLB, with a consensus rating of "Buy."  The average target price is significantly higher than the current price, indicating potential upside. *Note: The lack of data about recent rating changes makes it impossible to fully asses that.*

**5) Recent Earnings Analysis**

| 날짜       | EPS     | 매출       |
|------------|---------|------------|
| 2025-11-10 | -0.03   | 0.16 B$    |
| 2025-08-07 | -0.13   | 0.14 B$    |
| 2025-05-08 | -0.12   | 0.12 B$    |
| 2024-11-12 | -0.1    | 0.10 B$    |
| 2025-11-10 | -0.1    | 0.10 B$    |

**Analysis:**

*   **EPS:** While still negative, the EPS is improving (less negative) over the recent quarter. This is a positive sign.
*   **Revenue:** Revenue is consistently growing, which is also a positive indicator.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $0.16B     | 36.96%        |
| 2025-06-30   | $0.14B     | 32.10%        |
| 2025-03-31   | $0.12B     | 28.76%        |
| 2024-12-31   | $0.13B     | 27.81%        |
| 2024-09-30   | $0.10B     | 26.71%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE        |
|--------------|------------|------------|
| 2025-09-30   | $1.28B     | -1.43%     |
| 2025-06-30   | $0.69B     | -9.65%     |
| 2025-03-31   | $0.43B     | -14.05%    |
| 2024-12-31   | $0.38B     | -13.69%    |
| 2024-09-30   | $0.42B     | -12.37%    |

**Analysis:**

*   **Revenue:** Consistent revenue growth, as seen in the earnings analysis.
*   **Profit Margin:** Profit margins are improving, but still need to continue.
*   **Equity:**  Equity has increased significantly in the most recent quarter, likely due to capital raises or positive financial performance.
*   **ROE:** ROE remains negative, indicating that the company is not yet generating profits on its equity. However, the ROE is improving.

**7) Comprehensive Analysis (Summary)**

Rocket Lab (RKLB) is a high-growth company with significant potential, but also considerable risk. The stock has significantly outperformed the S&P 500, driven by strong revenue growth and improving profitability. Analyst sentiment is positive, and recent news highlights potential upside from government contracts and successful launches.

**Key Positives:**

*   Strong revenue growth.
*   Improving profit margins and EPS.
*   Positive analyst sentiment and high target prices.
*   Potential growth from government contracts and new deals.
*   Technically approaching oversold conditions.

**Key Risks:**

*   High volatility and maximum drawdown.
*   Negative ROE, indicating the company is not yet profitable.
*   Delay of Neutron project can have negative effects.
*   Recent upward trend losing momentum.

**Overall, RKLB appears to be a potentially attractive investment for those with a high-risk tolerance and a long-term investment horizon. The company's growth trajectory and positive news flow suggest that it could continue to outperform the market. However, investors should be aware of the risks and be prepared for potential volatility.**


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.